Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
08:00am, Thursday, 19'th Feb 2026
The only FDA‑approved locally applied antibiotic used with scaling and root planing (SRP) marks a quarter‑century of clinical use LAVAL, QC, Feb. 19, 2026 /PRNewswire/ -- Bausch Health Companies I
Here's What Key Metrics Tell Us About Bausch (BHC) Q4 Earnings
09:00pm, Wednesday, 18'th Feb 2026
The headline numbers for Bausch (BHC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Bausch Health (BHC) Q4 Earnings Lag Estimates
08:21pm, Wednesday, 18'th Feb 2026
Bausch Health (BHC) came out with quarterly earnings of $1.08 per share, missing the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $1.15 per share a year ago.
Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript
08:14pm, Wednesday, 18'th Feb 2026
Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
04:05pm, Wednesday, 18'th Feb 2026
Fourth Quarter Consolidated Revenues of $2.80 billion, up 9% on a Reported basis and up 6% on an Organic (non-GAAP) 1 basis over the prior year period Full-Year Consolidated Revenues of $10.27 bill
John Paulson's Strategic Moves: Madrigal Pharmaceuticals Inc. Sees a -3.09% Impact
06:08pm, Tuesday, 17'th Feb 2026
Insights into John Paulson (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing John Paulson (Trades, Portfolio) recently submitted the 13F filing for the four
Curious about Bausch (BHC) Q4 Performance? Explore Wall Street Estimates for Key Metrics
10:16am, Tuesday, 17'th Feb 2026
Get a deeper insight into the potential performance of Bausch (BHC) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
07:00am, Tuesday, 17'th Feb 2026
LAVAL, QC, Feb. 17, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Executive Vice President and CFO Jean-Jacques (JJ) Charhon, along with other management t
What to Expect From These Drug/Biotech Players This Earnings Season?
03:16pm, Monday, 16'th Feb 2026
Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week.
Bausch Health (BHC) Reports Next Week: Wall Street Expects Earnings Growth
11:01am, Wednesday, 11'th Feb 2026
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program
08:00am, Wednesday, 11'th Feb 2026
Bausch Health to Provide Scholarships to 10 Students Living with GI Diseases LAVAL, QC, Feb. 11, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology (GI) b
Overlooked and Undervalued: Why Bausch Health Companies Deserves Attention
11:00pm, Tuesday, 03'rd Feb 2026
There's a good reason why Bausch Health shares are experiencing yet another pullback. A recent clinical trial setback points to further trouble ahead.
BHC's Late-Stage Liver Cirrhosis Studies Fail, Stock Down
03:10pm, Tuesday, 27'th Jan 2026
Bausch Health shares slide after late-stage RED-C trials for rifaximin SSD fail, derailing plans to expand Xifaxan's cirrhosis-related use.
Down 17.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Bausch (BHC)
10:36am, Monday, 26'th Jan 2026
Bausch (BHC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ear
Bausch Health Cos (NYSE:BHC) Shares Gap Down – Here’s Why
03:54am, Sunday, 25'th Jan 2026
Bausch Health Cos Inc. (NYSE: BHC - Get Free Report)'s share price gapped down before the market opened on Friday. The stock had previously closed at $6.57, but opened at $6.22. Bausch Health Cos shar
